Similar Articles
1681 Systemic gemcitabine combined with intra-arterial low-dose cisplatin and 5-fluorouracil for advanced hepatocellular carcinoma: Seven cases
1682 Radiotherapy for 65 patients with advanced unresectable hepatocellular carcinoma
1683 Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma
1684 Natural history of hepatitis-related hepatocellular carcinoma
1685 Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era
1686 Radioembolization for the treatment of unresectable hepatocellular carcinoma: A clinical review
1687 Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma
1688 Is human hepatocellular carcinoma a hormone-responsive tumor?
1689 Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma
1690 Activins and activin antagonists in hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA